{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:09:25Z","timestamp":1786982965461,"version":"build-2736575974"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s42000-024-00587-2","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T16:01:57Z","timestamp":1722009717000},"page":"801-817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Testosterone therapy for functional hypogonadism in middle-aged and elderly males: current evidence and future perspectives"],"prefix":"10.1007","volume":"23","author":[{"given":"Nikolaos","family":"Theodorakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3597-1187","authenticated-orcid":false,"given":"Georgios","family":"Feretzakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Vamvakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios S.","family":"Verykios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis","family":"Polymeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"587_CR1","unstructured":"World Health Organization. World Population Ageing (2019) https:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/ageing\/WorldPopulationAgeing2019-Report.pdf. Accessed April 4 2024"},{"issue":"1","key":"587_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/eurpub\/ckac160","volume":"33","author":"KM Iburg","year":"2023","unstructured":"Iburg KM, Charalampous P, Allebeck P et al (2023) Burden of disease among older adults in Europe-trends in mortality and disability, 1990\u20132019. Eur J Public Health 33(1):121\u2013126. https:\/\/doi.org\/10.1093\/eurpub\/ckac160","journal-title":"Eur J Public Health"},{"key":"587_CR3","doi-asserted-by":"publisher","unstructured":"Polidori CM (2021) Physiology of aging as a basis of complexity in Aging Medicine and Geriatrics. Springer EBooks, pp 3824\u20133829. https:\/\/doi.org\/10.1007\/978-3-030-22009-9_548","DOI":"10.1007\/978-3-030-22009-9_548"},{"issue":"9","key":"587_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.4103\/2230-8210.123552","volume":"17","author":"P Singh","year":"2013","unstructured":"Singh P (2013) Andropause: current concepts. Indian J Endocrinol Metab 17(9):621. https:\/\/doi.org\/10.4103\/2230-8210.123552","journal-title":"Indian J Endocrinol Metab"},{"issue":"S3","key":"587_CR5","first-page":"20","volume":"27","author":"M Khera","year":"2020","unstructured":"Khera M (2020) Controversies with testosterone therapy. Can J Urol 27(S3):20\u201323","journal-title":"Can J Urol"},{"issue":"3","key":"587_CR6","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1210\/er.2017-00234","volume":"39","author":"PJ Snyder","year":"2018","unstructured":"Snyder PJ, Bhasin S, Cunningham GR et al (2018) Lessons from the testosterone trials. Endocr Rev 39(3):369\u2013386. https:\/\/doi.org\/10.1210\/er.2017-00234","journal-title":"Endocr Rev"},{"issue":"2","key":"587_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/nejmoa2215025","volume":"389","author":"AM Lincoff","year":"2023","unstructured":"Lincoff AM, Bhasin S, Flevaris P et al (2023) Cardiovascular Safety of testosterone-replacement therapy. N Engl J Med 389(2):107\u2013111. https:\/\/doi.org\/10.1056\/nejmoa2215025","journal-title":"N Engl J Med"},{"issue":"23","key":"587_CR8","doi-asserted-by":"publisher","first-page":"12735","DOI":"10.3390\/ijms222312735","volume":"22","author":"OO Oduwole","year":"2021","unstructured":"Oduwole OO, Huhtaniemi IT, Misrahi M (2021) The roles of luteinizing hormone, follicle-stimulating hormone and testosterone in spermatogenesis and folliculogenesis revisited. Int J Mol Sci 22(23):12735. https:\/\/doi.org\/10.3390\/ijms222312735","journal-title":"Int J Mol Sci"},{"issue":"1","key":"587_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1210\/jcem-53-1-58","volume":"53","author":"JF Dunn","year":"1981","unstructured":"Dunn JF, Nisula BC, Rodbard D (1981) Transport of Steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 53(1):58\u201368. https:\/\/doi.org\/10.1210\/jcem-53-1-58","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"587_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1310\/hpj5109-712","volume":"51","author":"C Schlich","year":"2016","unstructured":"Schlich C, Romanelli F (2016) Issues surrounding testosterone replacement therapy. Hosp Pharm 51(9):712\u2013720. https:\/\/doi.org\/10.1310\/hpj5109-712","journal-title":"Hosp Pharm"},{"issue":"3","key":"587_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1210\/er.2016-1067","volume":"38","author":"RS Swerdloff","year":"2017","unstructured":"Swerdloff RS, Dudley RE, Page ST et al (2017) Dihydrotestosterone: Biochemistry, Physiology, and clinical implications of elevated blood levels. Endocr Rev 38(3):220\u2013254. https:\/\/doi.org\/10.1210\/er.2016-1067","journal-title":"Endocr Rev"},{"issue":"1","key":"587_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1053\/beem.2001.0120","volume":"15","author":"Y Jin","year":"2001","unstructured":"Jin Y, Penning TM (2001) Steroid 5\u03b1-reductases and 3\u03b1-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism. Best Pract Res Clin Endocrinol Metab 15(1):79\u201394. https:\/\/doi.org\/10.1053\/beem.2001.0120","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"11","key":"587_CR13","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/nejmoa1206168","volume":"369","author":"JS Finkelstein","year":"2013","unstructured":"Finkelstein JS, Lee H, Burnett-Bowie S-AM et al (2013) Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 369(11):1011\u20131022. https:\/\/doi.org\/10.1056\/nejmoa1206168","journal-title":"N Engl J Med"},{"issue":"1","key":"587_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10522-022-10002-1","volume":"24","author":"JM Ketchem","year":"2023","unstructured":"Ketchem JM, Bowman EJ, Isales CM (2023) Male sex hormones, aging, and inflammation. Biogerontology 24(1):1\u201325. https:\/\/doi.org\/10.1007\/s10522-022-10002-1","journal-title":"Biogerontology"},{"issue":"7","key":"587_CR15","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.2337\/dc09-1788","volume":"33","author":"C Li","year":"2010","unstructured":"Li C, Ford ES, Li B, Giles WH, Liu S (2010) Association of Testosterone and Sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care 33(7):1618\u20131624. https:\/\/doi.org\/10.2337\/dc09-1788","journal-title":"Diabetes Care"},{"issue":"7","key":"587_CR16","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1210\/jc.2005-0553","volume":"90","author":"G Johannsson","year":"2005","unstructured":"Johannsson G, Gibney J, Wolthers T et al (2005) Independent and Combined effects of Testosterone and Growth hormone on Extracellular Water in Hypopituitary Men. J Clin Endocrinol Metab 90(7):3989\u20133994. https:\/\/doi.org\/10.1210\/jc.2005-0553","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"587_CR17","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1210\/jc.2017-00757","volume":"102","author":"S Santosa","year":"2017","unstructured":"Santosa S, Bush NC, Jensen MD (2017) Acute Testosterone Deficiency alters adipose tissue fatty acid storage. J Clin Endocrinol Metab 102(8):3056\u20133064. https:\/\/doi.org\/10.1210\/jc.2017-00757","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"587_CR18","doi-asserted-by":"publisher","first-page":"bvad003","DOI":"10.1210\/jendso\/bvac003","volume":"6","author":"E Carmina","year":"2022","unstructured":"Carmina E, Dreno B, Lucky WA et al (2022) Female adult acne and androgen excess: a Report from the multidisciplinary androgen excess and PCOS Committee. J Endocr Soc 6(3):bvad003. https:\/\/doi.org\/10.1210\/jendso\/bvac003","journal-title":"J Endocr Soc"},{"issue":"13","key":"587_CR19","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.clinbiochem.2011.06.984","volume":"44","author":"MK Arora","year":"2011","unstructured":"Arora MK, Yadav A, Saini V (2011) Role of hormones in acne vulgaris. Clin Biochem 44(13):1035\u20131040. https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.06.984","journal-title":"Clin Biochem"},{"issue":"7","key":"587_CR20","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1007\/s00213-021-05818-7","volume":"238","author":"R Chegeni","year":"2021","unstructured":"Chegeni R, Pallesen S, McVeigh J, Sagoe D (2021) Anabolic-androgenic steroid administration increases self-reported aggression in healthy males: a systematic review and meta-analysis of experimental studies. Psychopharmacology 238(7):1911\u20131922. https:\/\/doi.org\/10.1007\/s00213-021-05818-7","journal-title":"Psychopharmacology"},{"issue":"1","key":"587_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0303-7207(96)03819-1","volume":"120","author":"CM Wilson","year":"1996","unstructured":"Wilson CM, McPhaul MJ (1996) A and B forms of the androgen receptor are expressed in a variety of human tissues. Mol Cell Endocrinol 120(1):51\u201357. https:\/\/doi.org\/10.1016\/0303-7207(96)03819-1","journal-title":"Mol Cell Endocrinol"},{"key":"587_CR22","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3389\/fimmu.2020.01647","volume":"11","author":"JV Alves","year":"2020","unstructured":"Alves JV, da Costa RM, Pereira CA et al (2020) Supraphysiological levels of Testosterone Induce Vascular Dysfunction via activation of the NLRP3 inflammasome. Front Immunol 11:1647. https:\/\/doi.org\/10.3389\/fimmu.2020.01647","journal-title":"Front Immunol"},{"issue":"7","key":"587_CR23","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1210\/jc.2007-1972","volume":"93","author":"FCW Wu","year":"2008","unstructured":"Wu FCW, Tajar A, Pye SR et al (2008) Hypothalamic-pituitary-testicular Axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93(7):2737\u20132745. https:\/\/doi.org\/10.1210\/jc.2007-1972","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"587_CR24","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1530\/eje-15-0380","volume":"173","author":"DJ Handelsman","year":"2015","unstructured":"Handelsman DJ, Yeap BB, Flicker L et al (2015) Age-specific population centiles for androgen status in men. Eur J Endocrinol 173(6):809\u2013817. https:\/\/doi.org\/10.1530\/eje-15-0380","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"587_CR25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1210\/jc.2006-1859","volume":"92","author":"TG Travison","year":"2007","unstructured":"Travison TG, Araujo AB, Kupelian V et al (2007) The relative contributions of aging, Health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 92(2):549\u2013555. https:\/\/doi.org\/10.1210\/jc.2006-1859","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"587_CR26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","volume":"87","author":"HA Feldman","year":"2002","unstructured":"Feldman HA, Longcope C, Derby CA et al (2002) Age trends in the level of serum testosterone and other hormones in Middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 87(2):589\u2013598. https:\/\/doi.org\/10.1210\/jcem.87.2.8201","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"587_CR27","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","volume":"86","author":"SM Harman","year":"2001","unstructured":"Harman SM, Metter EJ, Tobin JD et al (2001) Longitudinal effects of Aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 86(2):724\u2013731. https:\/\/doi.org\/10.1210\/jcem.86.2.7219","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"587_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000446656","volume":"104","author":"F Xia","year":"2016","unstructured":"Xia F, Wang N, Han B et al (2016) Hypothalamic-pituitary-gonadal Axis in Aging men and women: increasing total testosterone in Aging men. Neuroendocrinology 104(3):291\u2013301. https:\/\/doi.org\/10.1159\/000446656","journal-title":"Neuroendocrinology"},{"issue":"6","key":"587_CR29","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1111\/andr.12719","volume":"8","author":"E Nieschlag","year":"2019","unstructured":"Nieschlag E (2019) Late-onset hypogonadism: a concept comes of age. Androl 8(6):1506\u20131511. https:\/\/doi.org\/10.1111\/andr.12719","journal-title":"Androl"},{"issue":"4","key":"587_CR30","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1210\/jc.2009-1796","volume":"95","author":"A Tajar","year":"2010","unstructured":"Tajar A, Forti G, O\u2019Neill TW et al (2010) Characteristics of secondary, primary, and compensated hypogonadism in Aging men: evidence from the Eur Male Ageing Study. J Clin Endocrinol Metab 95(4):1810\u20131818. https:\/\/doi.org\/10.1210\/jc.2009-1796","journal-title":"J Clin Endocrinol Metab"},{"key":"587_CR31","doi-asserted-by":"publisher","first-page":"112249","DOI":"10.1016\/j.exger.2023.112249","volume":"179","author":"P Xu","year":"2023","unstructured":"Xu P, Zeng R, Wan Q et al (2023) Aging-related increases in serum sex hormone-binding globulin levels in men might be related to increased synthesis. Exp Gerontol 179:112249. https:\/\/doi.org\/10.1016\/j.exger.2023.112249","journal-title":"Exp Gerontol"},{"key":"587_CR32","doi-asserted-by":"publisher","unstructured":"Winters SJ (2020) SHBG and total testosterone levels in men with adult onset hypogonadism: what are we overlooking? Clin Diabetes Endocrinol 6(1). https:\/\/doi.org\/10.1186\/s40842-020-00106-3","DOI":"10.1186\/s40842-020-00106-3"},{"issue":"2","key":"587_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1056\/NEJMoa0911101","volume":"363","author":"FCW Wu","year":"2010","unstructured":"Wu FCW, Tajar A, Beynon JM et al (2010) Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 363(2):123\u2013135. https:\/\/doi.org\/10.1056\/NEJMoa0911101","journal-title":"N Engl J Med"},{"issue":"6","key":"587_CR34","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1210\/jcem-56-6-1278","volume":"56","author":"WJ Bremner","year":"1983","unstructured":"Bremner WJ, Vitiello MV, Prinz PN (1983) Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 56(6):1278\u20131281. https:\/\/doi.org\/10.1210\/jcem-56-6-1278","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"587_CR35","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.3390\/cells10113114","volume":"10","author":"ME Matzkin","year":"2021","unstructured":"Matzkin ME, Calandra RS, Rossi SP et al (2021) Hallmarks of testicular aging: the challenge of anti-inflammatory and antioxidant therapies using natural and\/or pharmacological compounds to improve the Physiopathological Status of the aged male gonad. Cells 10(11):3114. https:\/\/doi.org\/10.3390\/cells10113114","journal-title":"Cells"},{"issue":"7","key":"587_CR36","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.3390\/ijms23073535","volume":"23","author":"B Barone","year":"2022","unstructured":"Barone B, Napolitano L, Abate M et al (2022) The role of Testosterone in the Elderly: what do we know? Int J Mol Sci 23(7):3535. https:\/\/doi.org\/10.3390\/ijms23073535","journal-title":"Int J Mol Sci"},{"issue":"7","key":"587_CR37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11934-018-0802-3","volume":"19","author":"DJ Mazur","year":"2018","unstructured":"Mazur DJ, Lipshultz LI (2018) Infertility in the Aging Male. Curr Urol Rep 19(7):54. https:\/\/doi.org\/10.1007\/s11934-018-0802-3","journal-title":"Curr Urol Rep"},{"issue":"3","key":"587_CR38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2164\/jandrol.05156","volume":"27","author":"WJG Hellstrom","year":"2006","unstructured":"Hellstrom WJG (2006) Semen and sperm reference ranges for men 45 years of Age and older. J Androl 27(3):421\u2013428. https:\/\/doi.org\/10.2164\/jandrol.05156","journal-title":"J Androl"},{"issue":"2","key":"587_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4103\/1008-682x.122365","volume":"16","author":"M Grossmann","year":"2014","unstructured":"Grossmann M, Tang Fui M, Dupuis P (2014) Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl 16(2):223. https:\/\/doi.org\/10.4103\/1008-682x.122365","journal-title":"Asian J Androl"},{"issue":"4","key":"587_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s13679-012-0029-4","volume":"1","author":"C Pelusi","year":"2012","unstructured":"Pelusi C, Pasquali R (2012) The significance of low testosterone levels in obese men. Curr Obes Rep 1(4):181\u2013190. https:\/\/doi.org\/10.1007\/s13679-012-0029-4","journal-title":"Curr Obes Rep"},{"issue":"6","key":"587_CR41","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/cen.12768","volume":"83","author":"LA Cooper","year":"2015","unstructured":"Cooper LA, Page ST, Amory JK et al (2015) The association of obesity with sex hormone-binding globulin is stronger than the association with ageing\u2013 implications for the interpretation of total testosterone measurements. Clin Endocrinol 83(6):828\u2013833. https:\/\/doi.org\/10.1111\/cen.12768","journal-title":"Clin Endocrinol"},{"issue":"6","key":"587_CR42","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1530\/eje-07-0893","volume":"158","author":"SA Paul Chubb","year":"2008","unstructured":"Paul Chubb SA, Hyde Z, Almeida OP et al (2008) Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in men Study. Eur J Endocrinol 158(6):785\u2013792. https:\/\/doi.org\/10.1530\/eje-07-0893","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"587_CR43","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1111\/andr.12770","volume":"8","author":"G Corona","year":"2020","unstructured":"Corona G, Goulis DG, Huhtaniemi I et al (2020) Eur Acad Androl (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males. Androl 8(5):970\u2013987. https:\/\/doi.org\/10.1111\/andr.12770","journal-title":"Androl"},{"issue":"2","key":"587_CR44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/cen.14633","volume":"96","author":"CN Jayasena","year":"2021","unstructured":"Jayasena CN, Anderson RA, Llahana S et al (2021) Society for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism. Clin Endocrinol 96(2):200\u2013219. https:\/\/doi.org\/10.1111\/cen.14633","journal-title":"Clin Endocrinol"},{"issue":"5","key":"587_CR45","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/jc.2018-00229","volume":"103","author":"S Bhasin","year":"2018","unstructured":"Bhasin S, Brito JP, Cunningham GR et al (2018) Testosterone therapy in men with hypogonadism: an endocr soc clin Pract Guideline. J Clin Endocrinol Metab 103(5):1715\u20131744. https:\/\/doi.org\/10.1210\/jc.2018-00229","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"587_CR46","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1210\/jc.2016-2935","volume":"102","author":"TG Travison","year":"2017","unstructured":"Travison TG, Vesper HW, Orwoll E et al (2017) Harmonized reference ranges for circulating testosterone levels in men of four Cohort studies in the United States and Europe. J Clin Endocrinol Metab 102(4):1161\u20131173. https:\/\/doi.org\/10.1210\/jc.2016-2935","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"587_CR47","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.beem.2010.11.004","volume":"25","author":"AB Araujo","year":"2011","unstructured":"Araujo AB, Wittert GA (2011) Endocrinology of the aging male. Best Pract Res Clin Endocrinol Metab 25(2):303\u2013319. https:\/\/doi.org\/10.1016\/j.beem.2010.11.004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"587_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/13685538.2021.1962840","volume":"24","author":"B Lunenfeld","year":"2021","unstructured":"Lunenfeld B, Mskhalaya G, Zitzmann M et al (2021) Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men. Aging Male 24(1):119\u2013138. https:\/\/doi.org\/10.1080\/13685538.2021.1962840","journal-title":"Aging Male"},{"issue":"12","key":"587_CR49","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1210\/jc.2003-031719","volume":"89","author":"AB Araujo","year":"2004","unstructured":"Araujo AB, O\u2019Donnell AB, Brambilla DJ et al (2004) Prevalence and incidence of Androgen Deficiency in Middle-aged and older men: estimates from the Mass Male Aging Study. J Clin Endocrinol Metab 89(12):5920\u20135926. https:\/\/doi.org\/10.1210\/jc.2003-031719","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"587_CR50","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/andr.12827","volume":"8","author":"V Rochira","year":"2020","unstructured":"Rochira V (2020) Late-onset hypogonadism: bone health. Androl 8(6):1539\u20131550. https:\/\/doi.org\/10.1111\/andr.12827","journal-title":"Androl"},{"key":"587_CR51","doi-asserted-by":"publisher","first-page":"797243","DOI":"10.3389\/fendo.2021.797243","volume":"12","author":"A Guligowska","year":"2021","unstructured":"Guligowska A, Chrzastek Z, Pawlikowski M et al (2021) Gonadotropins at Advanced Age - perhaps they are not so bad? Correlations between gonadotropins and Sarcopenia indicators in older adults. Front Endocrinol 12:797243. https:\/\/doi.org\/10.3389\/fendo.2021.797243","journal-title":"Front Endocrinol"},{"key":"587_CR52","doi-asserted-by":"publisher","unstructured":"Lee K, Kao P, Yang C, Chen et al (2023) Effects of Testosterone replacement therapy on muscle strength in older men with low to low-normal testosterone levels: a systematic review and Meta-analysis. Gerontol 69(10):1157\u20131166. https:\/\/doi.org\/10.1159\/000532062","DOI":"10.1159\/000532062"},{"issue":"1","key":"587_CR53","doi-asserted-by":"publisher","first-page":"9742","DOI":"10.1007\/s11357-014-9742-0","volume":"37","author":"WK Neto","year":"2015","unstructured":"Neto WK, Gama EF, Rocha LY et al (2015) Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies. Age 37(1):9742. https:\/\/doi.org\/10.1007\/s11357-014-9742-0","journal-title":"Age"},{"issue":"9","key":"587_CR54","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.eprac.2023.04.013","volume":"29","author":"J Buratto","year":"2023","unstructured":"Buratto J, Kirk B, Phu S et al (2023) Safety and Efficacy of Testosterone Therapy on Musculoskeletal Health and Clinical outcomes in men: a systematic review and Meta-analysis of Randomized Placebo-controlled trials. Endocr Pract 29(9):727\u2013734. https:\/\/doi.org\/10.1016\/j.eprac.2023.04.013","journal-title":"Endocr Pract"},{"key":"587_CR55","doi-asserted-by":"publisher","first-page":"111106","DOI":"10.1016\/j.exger.2020.111106","volume":"142","author":"SM Parahiba","year":"2020","unstructured":"Parahiba SM, Ribeiro \u00c9CT, Corr\u00eaa C et al (2020) Effect of testosterone supplementation on sarcopenic components in middle-aged and elderly men: a systematic review and meta-analysis. Exp Gerontol 142:111106. https:\/\/doi.org\/10.1016\/j.exger.2020.111106","journal-title":"Exp Gerontol"},{"key":"587_CR56","doi-asserted-by":"publisher","unstructured":"Mangolim M AS, Brito, de AR, Nunes-Nogueira VdosS (2022) Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis. Eur J Endocrinol 186(1):123\u2013135. https:\/\/doi.org\/10.1530\/eje-21-0473","DOI":"10.1530\/eje-21-0473"},{"issue":"3","key":"587_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/nejmoa2308836","volume":"390","author":"PJ Snyder","year":"2024","unstructured":"Snyder PJ, Bauer DC, Ellenberg SS et al (2024) Testosterone treatment and fractures in men with hypogonadism. N Engl J Med 390(3):203\u2013211. https:\/\/doi.org\/10.1056\/nejmoa2308836","journal-title":"N Engl J Med"},{"issue":"3","key":"587_CR58","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/jcsm.12291","volume":"9","author":"JW Skinner","year":"2018","unstructured":"Skinner JW, Otzel DM, Bowser A et al (2018) Muscular responses to testosterone replacement vary by administration route: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 9(3):465\u2013481. https:\/\/doi.org\/10.1002\/jcsm.12291","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"12","key":"587_CR59","doi-asserted-by":"publisher","first-page":"E1035","DOI":"10.1152\/ajpendo.00111.2015","volume":"308","author":"SE Borst","year":"2015","unstructured":"Borst SE, Yarrow JF (2015) Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men. Am J Physiol - Endocrinol Metab 308(12):E1035\u2013E1042. https:\/\/doi.org\/10.1152\/ajpendo.00111.2015","journal-title":"Am J Physiol - Endocrinol Metab"},{"issue":"10","key":"587_CR60","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1016\/s2666-7568(23)00169-1","volume":"4","author":"J Hudson","year":"2023","unstructured":"Hudson J, Cruickshank M, Quinton R et al (2023) Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis. Lancet Health Longev 4(10):e561\u2013e572. https:\/\/doi.org\/10.1016\/s2666-7568(23)00169-1","journal-title":"Lancet Health Longev"},{"issue":"2","key":"587_CR61","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/dme.13553","volume":"35","author":"M Algeffari","year":"2018","unstructured":"Algeffari M, Jayasena CN, MacKeith P et al (2018) Testosterone therapy for sexual dysfunction in men with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabet Med 35(2):195\u2013202. https:\/\/doi.org\/10.1111\/dme.13553","journal-title":"Diabet Med"},{"issue":"4","key":"587_CR62","doi-asserted-by":"publisher","first-page":"861","DOI":"10.5534\/wjmh.220171","volume":"41","author":"HJ Yang","year":"2023","unstructured":"Yang HJ, Kim KH, Kim DS et al (2023) The Effect of Testosterone replacement on sexual function in the Elderly: a systematic review and Meta-analysis. World J Men\u2019s Health 41(4):861\u2013873. https:\/\/doi.org\/10.5534\/wjmh.220171","journal-title":"World J Men\u2019s Health"},{"key":"587_CR63","doi-asserted-by":"publisher","unstructured":"Zhang Z, Kang D, Li H (2020) Testosterone and cognitive impairment or dementia in Middle-aged or aging males: causation and intervention, a systematic review and Meta-analysis. J Geriatr Psychiatry Neurol 089198872093335. https:\/\/doi.org\/10.1177\/0891988720933351","DOI":"10.1177\/0891988720933351"},{"issue":"4","key":"587_CR64","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1007\/s12035-015-9315-y","volume":"53","author":"W Lv","year":"2015","unstructured":"Lv W, Du N, Liu Y et al (2015) Low testosterone level and risk of Alzheimer\u2019s Disease in the Elderly men: a systematic review and Meta-analysis. Mol Neurobiol 53(4):2679\u20132684. https:\/\/doi.org\/10.1007\/s12035-015-9315-y","journal-title":"Mol Neurobiol"},{"issue":"11","key":"587_CR65","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.jagp.2019.05.008","volume":"27","author":"S Tan","year":"2019","unstructured":"Tan S, Sohrabi HR, Weinborn M et al (2019) Effects of Testosterone supplementation on separate cognitive domains in cognitively healthy older men: a Meta-analysis of current randomized clinical trials. Am J Geriatr Psychiatry 27(11):1232\u20131246. https:\/\/doi.org\/10.1016\/j.jagp.2019.05.008","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"587_CR66","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/01.pra.0000358315.88931.fc","volume":"15","author":"FA Zarrouf","year":"2009","unstructured":"Zarrouf FA, Artz S, Griffith J et al (2009) Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract 15(4):289\u2013305. https:\/\/doi.org\/10.1097\/01.pra.0000358315.88931.fc","journal-title":"J Psychiatr Pract"},{"issue":"1","key":"587_CR67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/jamapsychiatry.2018.2734","volume":"76","author":"A Walther","year":"2019","unstructured":"Walther A, Breidenstein J, Miller R (2019) Association of Testosterone Treatment with alleviation of depressive symptoms in men. JAMA Psychiatry 76(1):31. https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.2734","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"587_CR68","doi-asserted-by":"publisher","first-page":"e381","DOI":"10.1016\/s2666-7568(22)00096-4","volume":"3","author":"J Hudson","year":"2022","unstructured":"Hudson J, Cruickshank M, Quinton R et al (2022) Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis. Lancet Health Longev 3(6):e381\u2013e393. https:\/\/doi.org\/10.1016\/s2666-7568(22)00096-4","journal-title":"Lancet Health Longev"},{"issue":"1","key":"587_CR69","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.eprac.2023.09.012","volume":"30","author":"A Sood","year":"2024","unstructured":"Sood A, Hosseinpour A, Sood A et al (2024) Cardiovascular outcomes of Hypogonadal men receiving testosterone replacement therapy: a Meta-analysis of Randomized controlled trials. Endocr Pract 30(1):2\u201310. https:\/\/doi.org\/10.1016\/j.eprac.2023.09.012","journal-title":"Endocr Pract"},{"issue":"6","key":"587_CR70","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/andr.12705","volume":"8","author":"M Grossmann","year":"2020","unstructured":"Grossmann M, Ng Tang Fui M, Cheung AS (2020) Late-onset hypogonadism: metabolic impact. Androl 8(6):1519\u20131529. https:\/\/doi.org\/10.1111\/andr.12705","journal-title":"Androl"},{"issue":"8","key":"587_CR71","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00345-018-2256-0","volume":"36","author":"J Zhang","year":"2018","unstructured":"Zhang J, Yang B, Xiao W et al (2018) Effects of testosterone supplement treatment in hypogonadal adult males with T2DM: a meta-analysis and systematic review. World J Urol 36(8):1315\u20131326. https:\/\/doi.org\/10.1007\/s00345-018-2256-0","journal-title":"World J Urol"},{"issue":"1","key":"587_CR72","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","volume":"9","author":"G Wittert","year":"2021","unstructured":"Wittert G, Bracken K, Robledo KP et al (2021) Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. Lancet Diabetes Endocrinol 9(1):32\u201345. https:\/\/doi.org\/10.1016\/S2213-8587(20)30367-3","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"587_CR73","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/andr.12425","volume":"6","author":"K-S Zhang","year":"2017","unstructured":"Zhang K-S, Zhao M\u2010J, An Q et al (2017) Effects of testosterone supplementation therapy on lipid metabolism in hypogonadal men with T2DM: a meta\u2010analysis of randomized controlled trials. Androl 6(1):37\u201346. https:\/\/doi.org\/10.1111\/andr.12425","journal-title":"Androl"},{"issue":"7","key":"587_CR74","doi-asserted-by":"publisher","first-page":"e019559","DOI":"10.1161\/jaha.120.019559","volume":"10","author":"M Qu","year":"2021","unstructured":"Qu M, Feng C, Wang X et al (2021) Association of Serum Testosterone and luteinizing hormone with blood pressure and risk of Cardiovascular Disease in Middle-aged and Elderly men. J Am Heart Assoc 10(7):e019559. https:\/\/doi.org\/10.1161\/jaha.120.019559","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"587_CR75","doi-asserted-by":"publisher","first-page":"768","DOI":"10.7326\/m23-2781","volume":"177","author":"BB Yeap","year":"2024","unstructured":"Yeap BB, Marriott RJ, Dwivedi G et al (2024) Associations of Testosterone and related hormones with all-cause and Cardiovascular Mortality and Incident Cardiovascular Disease in men. Ann Intern Med 177(6):768\u2013781. https:\/\/doi.org\/10.7326\/m23-2781","journal-title":"Ann Intern Med"},{"issue":"6","key":"587_CR76","doi-asserted-by":"publisher","first-page":"826","DOI":"10.7326\/m24-0875","volume":"177","author":"BD Anawalt","year":"2024","unstructured":"Anawalt BD (2024) The relationship of sex steroid hormones and clinical outcomes is complex. Ann Intern Med 177(6):826\u2013827. https:\/\/doi.org\/10.7326\/m24-0875","journal-title":"Ann Intern Med"},{"issue":"2","key":"587_CR77","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/nejmoa1000485","volume":"363","author":"S Basaria","year":"2010","unstructured":"Basaria S, Coviello AD, Travison TG et al (2010) Adverse events Associated with Testosterone Administration. N Engl J Med 363(2):109\u2013122. https:\/\/doi.org\/10.1056\/nejmoa1000485","journal-title":"N Engl J Med"},{"key":"587_CR78","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5968","author":"C Martinez","year":"2016","unstructured":"Martinez C, Suissa S, Rietbrock S et al (2016) Testosterone treatment and risk of venous thromboembolism: population based case-control study. BMJ i5968. https:\/\/doi.org\/10.1136\/bmj.i5968","journal-title":"BMJ i5968"},{"issue":"12","key":"587_CR79","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1080\/0284186X.2023.2278189","volume":"62","author":"A Siltari","year":"2023","unstructured":"Siltari A, Murtola TJ, Kausz J et al (2023) Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men. Acta Oncol (Stockh) 62(12):1898\u20131904. https:\/\/doi.org\/10.1080\/0284186X.2023.2278189","journal-title":"Acta Oncol (Stockh)"},{"issue":"7","key":"587_CR80","doi-asserted-by":"publisher","first-page":"e008755","DOI":"10.1161\/circheartfailure.121.008755","volume":"15","author":"E Di Lodovico","year":"2022","unstructured":"Di Lodovico E, Facondo P, Delbarba A et al (2022) Testosterone, hypogonadism, and Heart failure. Circ Heart Fail 15(7):e008755. https:\/\/doi.org\/10.1161\/circheartfailure.121.008755","journal-title":"Circ Heart Fail"},{"issue":"15","key":"587_CR81","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/eurjpc\/zwab020","volume":"28","author":"A Cittadini","year":"2021","unstructured":"Cittadini A, Salzano A, Iacoviello M et al (2021) Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry. Eur J Prev Cardiol 28(15):1691\u20131700. https:\/\/doi.org\/10.1093\/eurjpc\/zwab020","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"587_CR82","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.hfc.2019.02.007","volume":"15","author":"A Salzano","year":"2019","unstructured":"Salzano A, D\u2019Assante R, Lander M et al (2019) Hormonal replacement therapy in Heart failure: focus on growth hormone and testosterone. Heart Fail Clin 15(3):377\u2013391. https:\/\/doi.org\/10.1016\/j.hfc.2019.02.007","journal-title":"Heart Fail Clin"},{"key":"587_CR83","doi-asserted-by":"publisher","unstructured":"Borst SE, Shuster JJ, Zou B et al (2014) Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis. BMC Med 12(1). https:\/\/doi.org\/10.1186\/s12916-014-0211-5","DOI":"10.1186\/s12916-014-0211-5"},{"issue":"11","key":"587_CR84","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s40266-019-00716-2","volume":"36","author":"A Yabluchanskiy","year":"2019","unstructured":"Yabluchanskiy A, Tsitouras PD (2019) Is testosterone replacement therapy in older men effective and safe? Drugs Aging 36(11):981\u2013989. https:\/\/doi.org\/10.1007\/s40266-019-00716-2","journal-title":"Drugs Aging"},{"issue":"1","key":"587_CR85","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/andro.2020.0001","volume":"1","author":"S La Vignera","year":"2020","unstructured":"La Vignera S, Calogero AE, Cannarella R et al (2020) Obstructive sleep apnea and testosterone replacement therapy. Androgens 1(1):10\u201314. https:\/\/doi.org\/10.1089\/andro.2020.0001","journal-title":"Androgens"},{"key":"587_CR86","doi-asserted-by":"publisher","first-page":"1219239","DOI":"10.3389\/frph.2023.1219239","volume":"5","author":"A Graziani","year":"2023","unstructured":"Graziani A, Grande G, Ferlin A (2023) The complex relation between obstructive sleep apnoea syndrome, hypogonadism and testosterone replacement therapy. Front Reprod Health 5:1219239. https:\/\/doi.org\/10.3389\/frph.2023.1219239","journal-title":"Front Reprod Health"},{"issue":"2","key":"587_CR87","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/andr.13111","volume":"10","author":"L Su","year":"2022","unstructured":"Su L, Meng Y-H, Zhang S-Z et al (2022) Association between obstructive sleep apnea and male serum testosterone: a systematic review and meta-analysis. Int J Androl 10(2):223\u2013231. https:\/\/doi.org\/10.1111\/andr.13111","journal-title":"Int J Androl"},{"issue":"6","key":"587_CR88","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1111\/andr.12772","volume":"8","author":"EP Miranda","year":"2020","unstructured":"Miranda EP, Torres LO (2020) Late-onset hypogonadism: prostate safety. Androl 8(6):1606\u20131613. https:\/\/doi.org\/10.1111\/andr.12772","journal-title":"Androl"},{"issue":"3","key":"587_CR89","doi-asserted-by":"publisher","first-page":"e410","DOI":"10.1097\/md.0000000000000410","volume":"94","author":"D-Y Kang","year":"2015","unstructured":"Kang D-Y, Li H-J (2015) The effect of testosterone replacement therapy on prostate-specific Antigen (PSA) levels in men being treated for Hypogonadism. Medicine 94(3):e410. https:\/\/doi.org\/10.1097\/md.0000000000000410","journal-title":"Medicine"},{"issue":"2","key":"587_CR90","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/pcan.2013.60","volume":"17","author":"Y Cui","year":"2014","unstructured":"Cui Y, Zong H, Yan H, Zhang Y (2014) The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 17(2):132\u2013143. https:\/\/doi.org\/10.1038\/pcan.2013.60","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"12","key":"587_CR91","doi-asserted-by":"publisher","first-page":"e2348692","DOI":"10.1001\/jamanetworkopen.2023.48692","volume":"6","author":"S Bhasin","year":"2023","unstructured":"Bhasin S, Travison TG, Pencina KM et al (2023) Prostate safety events during testosterone replacement therapy in men with hypogonadism: a Randomized Clinical Trial. JAMA Netw Open 6(12):e2348692. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.48692","journal-title":"JAMA Netw Open"},{"issue":"10","key":"587_CR92","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.urolonc.2019.06.007","volume":"37","author":"MK Parizi","year":"2019","unstructured":"Parizi MK, Abufaraj M, Fajkovi\u0107 H et al (2019) Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: a systematic literature review and meta-analysis. Urol Oncol 37(10):637\u2013646. https:\/\/doi.org\/10.1016\/j.urolonc.2019.06.007","journal-title":"Urol Oncol"},{"issue":"8","key":"587_CR93","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.urolonc.2020.04.008","volume":"38","author":"L Lenfant","year":"2020","unstructured":"Lenfant L, Leon P, Cancel-Tassin G et al (2020) Testosterone replacement therapy (TRT) and prostate cancer: an updated systematic review with a focus on previous or active localized prostate cancer. Urol Oncol 38(8):661\u2013670. https:\/\/doi.org\/10.1016\/j.urolonc.2020.04.008","journal-title":"Urol Oncol"},{"issue":"1","key":"587_CR94","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/andr.13299","volume":"11","author":"RJ Valderr\u00e1bano","year":"2022","unstructured":"Valderr\u00e1bano RJ, Pencina K, Storer TW et al (2022) Testosterone replacement in prostate cancer survivors with testosterone deficiency: study protocol of a randomized controlled trial. Andrology 11(1):93\u2013102. https:\/\/doi.org\/10.1111\/andr.13299","journal-title":"Andrology"},{"issue":"10","key":"587_CR95","doi-asserted-by":"publisher","first-page":"429e1","DOI":"10.1016\/j.urolonc.2023.06.002","volume":"41","author":"J Daza","year":"2023","unstructured":"Daza J, Ahmad A, Shabir U et al (2023) Does testosterone replacement therapy increase the risk of conversion to treatment in patients with prostate cancer on active surveillance? Urol Oncol 41(10):429e1\u2013429e7. https:\/\/doi.org\/10.1016\/j.urolonc.2023.06.002","journal-title":"Urol Oncol"},{"issue":"6","key":"587_CR96","doi-asserted-by":"publisher","first-page":"e220061","DOI":"10.1530\/ec-22-0061","volume":"11","author":"AC van der Burgh","year":"2022","unstructured":"van der Burgh AC, Khan SR, Neggers SJCM, Hoorn EJ, Chaker L (2022) The role of serum testosterone and dehydroepiandrosterone sulfate in kidney function and clinical outcomes in chronic kidney disease: a systematic review and meta-analysis. Endocr Connect 11(6):e220061. https:\/\/doi.org\/10.1530\/ec-22-0061","journal-title":"Endocr Connect"},{"key":"587_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/3630429","volume":"2022","author":"L Li","year":"2022","unstructured":"Li L, Ju H, Jin H et al (2022) Low testosterone level and risk of adverse clinical events among male patients with chronic kidney disease: a systematic review and Meta-analysis of Cohort studies. J Healthc Eng 2022:1\u201310. https:\/\/doi.org\/10.1155\/2022\/3630429","journal-title":"J Healthc Eng"},{"issue":"3","key":"587_CR98","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.ajkd.2014.03.010","volume":"64","author":"KK Khurana","year":"2014","unstructured":"Khurana KK, Navaneethan SD, Arrigain S, Schold JD, Nally JV, Shoskes DA (2014) Serum testosterone levels and mortality in men with CKD stages 3\u20134. Am J Kidney Dis 64(3):367\u2013374. https:\/\/doi.org\/10.1053\/j.ajkd.2014.03.010","journal-title":"Am J Kidney Dis"},{"issue":"16","key":"587_CR99","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.3390\/nu14163444","volume":"14","author":"R Skiba","year":"2022","unstructured":"Skiba R, Rymarz A, Matyjek A, Dymus J, Wo\u017aniak-Kosek A, Syry\u0142o T et al (2022) Testosterone replacement therapy in chronic kidney Disease patients. Nutrients 14(16):3444. https:\/\/doi.org\/10.3390\/nu14163444","journal-title":"Nutrients"},{"issue":"3","key":"587_CR100","doi-asserted-by":"publisher","first-page":"155798832091725","DOI":"10.1177\/1557988320917258","volume":"14","author":"JK Yeo","year":"2020","unstructured":"Yeo JK, Koo HS, Yu J, Park MG (2020) Effects of Testosterone Treatment on Quality of Life in patients with chronic kidney disease. Am J Men\u2019s Health 14(3):1557988320917258. https:\/\/doi.org\/10.1177\/1557988320917258","journal-title":"Am J Men\u2019s Health"},{"issue":"9868","key":"587_CR101","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/s0140-6736(12)62167-9","volume":"381","author":"A Clegg","year":"2013","unstructured":"Clegg A, Young J, Iliffe S et al (2013) Frailty in elderly people. Lancet 381(9868):752\u2013762. https:\/\/doi.org\/10.1016\/s0140-6736(12)62167-9","journal-title":"Lancet"},{"issue":"3","key":"587_CR102","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s41999-022-00614-8","volume":"13","author":"X Peng","year":"2022","unstructured":"Peng X, Hou L, Zhao Y et al (2022) Frailty and testosterone level in older adults: a systematic review and meta-analysis. Eur Geriatr Med 13(3):663\u2013673. https:\/\/doi.org\/10.1007\/s41999-022-00614-8","journal-title":"Eur Geriatr Med"},{"issue":"8","key":"587_CR103","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jsxm.2022.05.145","volume":"19","author":"G Fallara","year":"2022","unstructured":"Fallara G, Pozzi E, Belladelli F et al (2022) Cardiovascular Morbidity and Mortality in men - findings from a Meta-analysis on the Time-related measure of risk of exogenous testosterone. J Sex Med 19(8):1243\u20131254. https:\/\/doi.org\/10.1016\/j.jsxm.2022.05.145","journal-title":"J Sex Med"},{"issue":"2","key":"587_CR104","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s40264-015-0348-y","volume":"39","author":"GI Hackett","year":"2015","unstructured":"Hackett GI (2015) Testosterone replacement therapy and mortality in older men. Drug Saf 39(2):117\u2013130. https:\/\/doi.org\/10.1007\/s40264-015-0348-y","journal-title":"Drug Saf"},{"issue":"1","key":"587_CR105","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.sxmr.2017.04.001","volume":"6","author":"SJ Ohlander","year":"2018","unstructured":"Ohlander SJ, Varghese B, Pastuszak AW (2018) Erythrocytosis following testosterone therapy. Sex Med Rev 6(1):77\u201385. https:\/\/doi.org\/10.1016\/j.sxmr.2017.04.001","journal-title":"Sex Med Rev"},{"key":"587_CR106","doi-asserted-by":"publisher","first-page":"107854","DOI":"10.1016\/j.maturitas.2023.107854","volume":"178","author":"GA Kanakis","year":"2023","unstructured":"Kanakis GA, Pofi R, Goulis DG, Isidori AM, Armeni E, Erel CT et al (2023) EMAS position statement: Testosterone replacement therapy in older men. Maturitas 178:107854. https:\/\/doi.org\/10.1016\/j.maturitas.2023.107854","journal-title":"Maturitas"},{"issue":"2","key":"587_CR107","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.esxm.2020.01.009","volume":"8","author":"AW Pastuszak","year":"2020","unstructured":"Pastuszak AW, Hu Y, Freid JD (2020) Occurrence of Pulmonary Oil Microembolism after Testosterone Undecanoate Injection: a Postmarketing Safety Analysis. Sex Med 8(2):237\u2013242. https:\/\/doi.org\/10.1016\/j.esxm.2020.01.009","journal-title":"Sex Med"},{"issue":"2","key":"587_CR108","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/jcm8020209","volume":"8","author":"YS Shin","year":"2019","unstructured":"Shin YS, Park JK (2019) The optimal indication for testosterone replacement therapy in late Onset Hypogonadism. J Clin Med 8(2):209. https:\/\/doi.org\/10.3390\/jcm8020209","journal-title":"J Clin Med"},{"key":"587_CR109","doi-asserted-by":"publisher","unstructured":"Lu T, Hu Y-H, Tsai C-F, Liu S-P, Chen P-L (2016) Applying machine learning techniques to the identification of late-onset hypogonadism in elderly men. SpringerPlus 5(1). https:\/\/doi.org\/10.1186\/s40064-016-2531-8","DOI":"10.1186\/s40064-016-2531-8"},{"issue":"1","key":"587_CR110","doi-asserted-by":"publisher","first-page":"139","DOI":"10.5534\/wjmh.190077","volume":"39","author":"JW Kim","year":"2021","unstructured":"Kim JW, Moon DG (2021) Optimizing Aging Male Symptom Questionnaire through genetic algorithms based machine learning techniques. World J Men\u2019s Health 39(1):139\u2013146. https:\/\/doi.org\/10.5534\/wjmh.190077","journal-title":"World J Men\u2019s Health"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00587-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-024-00587-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00587-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T06:12:50Z","timestamp":1730095970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-024-00587-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["587"],"URL":"https:\/\/doi.org\/10.1007\/s42000-024-00587-2","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}